Cleocin Phosphate Injection, Solution
Product Images NDC 0404-9837
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 0404-9837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
Table 1 shows the average peak and trough serum concentrations of active Clindamycin after dosing with Clindamycin Phosphate in healthy adult males and pediatric patients. The table includes different dosage regimens and their corresponding peak and trough concentrations in mog/mL. It is important to note that data in the healthy adult male group was obtained post equilibrium and data in the pediatric patient group was from patients being treated for infection.*
Image2.jpg (Image2)
Image3.jpg (Image3)
Image4.jpg (Image4)
Image5.jpg (Image5)
This is a table with information about the size and amount of Clindamycin Phosphate in each vial. The vials come in three different sizes: 2mL, 4mL, and 6mL. Each box contains 25 vials. The amount of Clindamycin Phosphate per vial varies, with the smallest containing 300 mg and the largest containing 900 mg.*
Image6.jpg (Image6)
This text refers to different dosages of a medication expressed in milligrams per 50 milliliters of solution, each available in different containers identified by their National Drug code (NDC) numbers. The indicated dosage strengths are 24-300mg, 24-600mg, and 24-900mg. However, no further information is available regarding the name or the usage of the medication.*
Label1.jpg (Label1)
This is a product description for Cleocin Phosphate, an injectable solution used for intravenous or intramuscular administration. It is a single-dose vial containing 150mg/mi of clindamycin phosphate, which is equivalent to 300mg of clindamycin, a type of antibiotic. The solution also contains disodium edetate and benzyl alcohol as a preservative. The pH is adjusted with sodium hydroxide or hydrochloric acid. The label warns that if the solution is given intravenously, it must be diluted before use. The product should be kept out of reach of children and stored at room temperature. The package contains more detailed information for the user, including manufacturer and lot information.*
Vialimage1.jpg (Vialimage1)
Vialimage2.jpg (Vialimage2)
Vialimage3.jpg (Vialimage3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.